Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. Stents are used to help prop open a vessel treated by balloon angioplasty because of the barotrauma caused by the extreme stretching of vessel walls. The stent enables to vessel to heal in an open position with collapsing. Drug eluting stents (DES) are coated in anti-proliferative drugs to precent scar tissue growth which can cause restenosis and occlude the vessel. DES require antiplatelet therapy because the drug carrier polymer on DES can cause thrombus inside the stent, even years after treatment, which is why bare metal stents are still used in some patients. This page includes news on coronary stents, carotid stents, peripheral stents, bioresorbable stents, and renal stents. 

FDA Panel Recommends Continued Use of Paclitaxel-coated Peripheral Devices
Feature | Peripheral Artery Disease (PAD) | Jeff Zagoudis, Associate Editor

August 28, 2019 — The U.S. Food and Drug Administration (FDA) released an updated MedWatch Alert this month on the ...

Home August 28, 2019
Home
News | Stents

August 21, 2019 — Increasing incidence of cardiovascular diseases worldwide is creating growth opportunities for the ...

Home August 21, 2019
Home
News | Peripheral Artery Disease (PAD)

August 1, 2019 — Less-invasive procedures to open severely clogged leg arteries were as good at helping people survive ...

Home August 01, 2019
Home
News | Stents Carotid

June 13, 2019 — Silk Road Medical Inc. announced the presentation of real-world data for the treatment of patients with ...

Home June 13, 2019
Home
Technology | Venous Therapies

May 6, 2019 — The U.S Food and Drug Administration (FDA) has cleared the Boston Scientific Vici Venous Stent System for ...

Home May 06, 2019
Home
News | Cath Lab

April 18, 2019 — The U.S. Food and Drug Administration published a draft guidance titled, “Technical Considerations for ...

Home April 18, 2019
Home
Technology | Peripheral Artery Disease (PAD)

April 15, 2019 – Intact Vascular Inc. received U.S. Food and Drug Administration (FDA) market clearance for the Tack ...

Home April 15, 2019
Home
Technology | Cath Lab

April 15, 2019 — Biotronik began its U.S. commercial launch of the PK Papyrus covered coronary stent system for use in ...

Home April 15, 2019
Home
Technology | Stents

April 3, 2019 — The U.S. Food and Drug Administration (FDA) recently granted an additional indication to Bard Peripheral ...

Home April 03, 2019
Home
Technology | Venous Therapies

April 3, 2019 — The U.S. Food and Drug Administration (FDA) recently cleared Bard Peripheral Vascular's Venovo Venous ...

Home April 03, 2019
Home
Technology

April 3, 2019 — Medtronic's Resolute Integrity Zotarolimus-eluting Coronary Stent System received an additional U.S ...

Home April 03, 2019
Home
Feature | Stents | Dave Fornell, Editor

February 22, 2019 — The U.S. Food and Drug Administration (FDA) has approved the Biotronik Orsiro drug-eluting stent ...

Home February 22, 2019
Home
Blog | Cath Lab

Clinical study data makes the world go around in cardiology and is the basis of setting guidelines in evidence-based ...

Home February 20, 2019
Home
The Boston Scientific Eluvia self-expanding, drug-eluting peripheral stent. It outperformed the Cook Zilver stent in the IMPERIAL Trial presented at TCT 2018.
Feature | Peripheral Artery Disease (PAD) | Dave Fornell, Editor

In recent years, there has been a lot of focus by vendors on developing better stenting technologies to treat peripheral ...

Home January 30, 2019
Home
The Medtronic Resolute Integrity drug-eluting stent is among the top three stents on the U.S. market. Outcomes for these stents are very similar, so the stents have largely become a commodity product purchased on price rather than clinical data. Stent advances and new stent technologies.
Feature | Stents | Dave Fornell, Editor

There was a lot of hype and high hopes pinned on bioresorbable stent technologies as the way of the future two years ago ...

Home January 29, 2019
Home
Subscribe Now